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Background: Spinal muscular atrophy (SMA) is caused by SMN1 dysfunction, and the copy number of SMN2 and
NAIP can modify the phenotype of SMA. The aim of this study was to analyze the copy numbers and gene
structures of SMA-related genes in Chinese SMA patients and unrelated healthy controls.
Methods: Forty-two Chinese SMA patients and two hundred and twelve unrelated healthy Chinese individuals
were enrolled in our study. The copy numbers and gene structures of SMA-related genes were measured by MLPA
assay.
Results: We identified a homozygous deletion of SMN1 in exons 7 and 8 in 37 of 42 patients (88.1%); the other 5
SMA patients (11.9%) had a single copy of SMN1 exon 8. The proportions of the 212 unrelated healthy controls with
different copy numbers for the normal SMN1 gene were 1 copy in 4 individuals (1.9%), 2 copies in 203 (95.7%) and
3 copies in 5 (2.4%). Three hybrid SMN genes and five genes that lack partial sequences were found in SMA
patients and healthy controls. Distributions of copy numbers for normal SMN2 and NAIP were significantly different
(P < 0.001) in people with and without SMA.
Conclusion: The copy numbers and gene structures of SMA-related genes were different in Chinese SMA patients
and healthy controls.
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Spinal muscular atrophy (SMA) is one of the most com-
mon autosomal recessive diseases and is characterized
by degeneration of spinal cord motor neurons, atrophy
of skeletal muscles, and generalized weakness [1]. The
incidence of SMA is approximately 1/6,000 to 1/10,000
live births, and the carrier frequency is about 1/42 in the
Chinese population [2]. SMA is divided into four clinical
types according to age of onset and achieved motor* Correspondence: gzxuxm@pub.guangzhou.gd.cn
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SMA is caused by the dysfunction of the survival motor
neuron (SMN) gene on chromosome 5q13.2. The two ver-
sions of SMN, SMN1 and SMN2, differ by only five nucleo-
tides. SMN1 produces a full-length transcript that encodes
functional SMN protein. About 94% of SMA patients have
a homozygous deletion of SMN1 exon 7. SMN1 can be ab-
sent because of deletion or SMN1-to-SMN2 conversion [3].
A single nucleotide transition in SMN2 exon 7 (c.840C >T)
relative to SMN1 causes most of the SMN2 pre-mRNA to
lack exon 7 and encode nonfunctional SMNΔ7 protein
[4]. However, about 10% of SMN2 pre-mRNA is normal
and can be translated into full-length SMN protein. SMN2
partially functionally compensates an SMN1 homozygoushis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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SMA severity. In addition to the SMN genes, the neuronal
apoptosis inhibitory protein (NAIP) gene, also located at
chromosome 5q13.2, is an SMA disease-related gene. The
copy number of NAIP is reported to be correlated with
SMA severity. SMA patients with fewer copies of NAIP
have more severe phenotypes than patients with more cop-
ies of NAIP [6,7]. Moreover, both SMN2 and NAIP copy
numbers were associated with the onset age, risk of death
and survival probability of SMA patients [8]. Therefore,
elucidating the gene copy numbers and structures of
SMN1, SMN2 and NAIP is important for analyzing the mo-
lecular mechanism of SMA and for SMA clinical diagnosis.
The SMN1, SMN2 and NAIP genes are all located at
5q13.2, an unstable chromosomal region that is prone to
deletion, duplication, and gene conversion. Copy num-
bers of SMN1 and SMN2 vary in humans. In Chinese
populations, up to 4 SMN1 or SMN2 genes are reported
in both healthy people and SMA patients [2,9]. In
addition, SMN gene deletions and rearrangements are
found in different populations [6,7,10]. Detecting copies
and gene structures of SMA-related genes is difficult be-
cause of the high homology between SMN1 and SMN2.
However, the multiple ligation-dependent probe amplifi-
cation (MLPA) assay has been established for detecting
deletions and duplications of SMA-related genes [11,12].
To determine the copy numbers and structures of
SMA-related genes in a Chinese population, we analyzed
SMN1, SMN2 and NAIP in 42 Chinese SMA patients
and 212 Chinese healthy individuals using MLPA assays.
Methods
Population and patient samples
A total of 212 peripheral blood samples were obtained
from unrelated healthy adults (108 men and 104 women)
at the Third Affiliated Hospital of Southern Medical Uni-
versity. In addition, we enrolled 42 unrelated SMA pa-
tients from four hospitals (18 patients from the Fuzhou
General Hospital of Nanjing Military Command, 18 from
the Shenzhen Maternity and Child Healthcare Hospital,
4 from the Liuzhou Municipal Maternity and Child
Healthcare Hospital, and 2 from the Prenatal Diagnosis
Center of Dongguan Maternal and Child Health Hos-
pital). All SMA patients were confirmed by MLPA assay
to have a homozygous deletion of SMN1 gene exon 7. All
healthy individuals and SMA patients were of Han ethnicity.
Ethical approval
Ethical approval for this study has been obtained from the
Ethical Committee of the Southern Medical University as
well as from partners including the Ethics Committee of
the Third Affiliated Hospital of the Southern Medical
University, the Ethics Committee of Fuzhou General Hos-
pital of Nanjing Military Command, the Ethics Committeeof Shenzhen Maternal and Child Health Care Hospital,
the Ethics Committee of Liuzhou Maternal and Child
Health Care Hospital and the Ethics Committee of Repro-
ductive Medical Center of Dongguan Maternal and Child
Health Care Hospital. Written informed consent was
obtained from all participants or guardians prior to the
study.MLPA technique
Human DNA was extracted from leukocytes in periph-
eral blood using a standard phenol/chloroform method.
SMN1, SMN2 and NAIP copy numbers were determined
by an MLPA technique using SALSA P021-A2 SMA kits
(MRC-Holland, Amsterdam, Netherlands) that amplify
37 regions throughout the genome for products between
140 and 463 bp. Of the amplified regions, 15 were target
sequences at the SMA locus on 5q13.2 and 22 were ref-
erence sequences. Ten probes were complementary to
SMN1, SMN2 and NAIP sequences. Because of the se-
quence similarity of SMN1 and SMN2, probes SMN1-1*,
SMN1-5*, SMN1-6* and SMN1-8* were complementary
to common regions in exons 1, 4, 6, 8 of either SMN1 or
SMN2. Probes SMN1-7# and SMN1-8# were specific for
SMN1 in exons 7 and 8. Probes SMN2-7# and SMN2-8#
were specific for SMN2 in exons 7 and 8. Probes NAIP-1#
and NAIP-08# were specific for NAIP in exons 13 and 5
(Figure 1). MLPA assays are a multiplex PCR strategy with
four steps: DNA denaturation and probe hybridization,
ligation of two probes, PCR of ligated probes, and separ-
ation of amplified fragments and data analysis. All experi-
mental procedures were carried out according to kit
instructions. MLPA products were separated and quanti-
fied by capillary electrophoresis using an ABI 3130XL
Genetic Analyzer with LIZ 500 as the internal size stand-
ard. Data were analyzed with the GeneMapper software
v3.2 package (Applied Biosystems, Foster city, CA). Intra-
sample normalization was by dividing the peak area of
each probe’s amplification product by the total area of ref-
erence probes only. Intersample normalization was by div-
iding the intranormalized probe ratio for a sample by the
average intranormalized probe ratio of two reference sam-
ples. Reference samples had two copies of SMN1, SMN2
and NAIP genes. Intervals for estimating the copy number
of each probe were defined according to the predefined
standards of Alías et al. [13].Statistical analysis
The distributions of samples with different SMN2 and
NAIP copy numbers from SMA patients and healthy in-
dividuals were compared using the Mann–Whitney U
test. A p-value of less than 0.05 was considered statisti-
cally significant. All statistical analyses used the SPSS
software package (version 13.0, SPSS Inc., Chicago, IL).
Figure 1 Schematic representation of SMA-related genes in MLPA assays. Gray, RAD17, SERF1B and GTF2H2, near the disease-determining
gene. Arrows, relative position and 5′-to-3′ direction of SMA-related genes. Blank boxes, exons (E). Important MLPA probes are above related
genes. *, probes complementary to common regions in exons 1, 4, 6, 8 of either SMN1 or SMN2; #, probes specific for SMN or NAIP genes.
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Gene copy number and structure in SMA patients
All SMA patients had a homozygous deletion of SMN1
exon 7. We also identified a homozygous deletion of
SMN1 exon 8 in 37 of 42 patients (88.1%); the other 5
SMA patients (11.9%) had a single copy of SMN1 exon
8. The proportions of SMA patients with various num-
bers of normal SMN2 copies were 1 copy in 2 patients
(4.8%), 2 copies in 14 (33.3%), 3 copies in 24 (57.1%) and
4 copies in 2 (4.8%). The proportions of SMA patients
with various numbers of normal NAIP were 0 copies in 4
patients (9.5%), 1 copy in 26 (61.9%) and 2 copies in 12
(28.6%). In addition, 10 patients (23.8%) had an NAIP gene
lacking exon 5 (pattern a in Figure 2), and 1 patient (2.4%)
had an SMN1 gene lacking exon 7 (pattern b in Figure 2).
SMN2 genes lacking partial sequences were also found in
SMA patients. Three patients (7.1%) had an SMN2
lacking exon 1 to exon 7 (pattern d in Figure 2), and
two (4.8%) had an SMN2 lacking exon 7 (pattern c in
Figure 2). We also found hybrid SMN genes in SMA
patients. A hybrid SMN gene in which exon 8 of SMN2
was converted to exon 8 of SMN1 (pattern e in Figure 2)
was found in 3 patients (7.1%), and a hybrid SMN geneFigure 2 Gene structures inferred from MLPA results. (a) NAIP gene lac
exon 7; (d) SMN2 gene lacking exon 1 to exon 7; (e) Hybrid SMN gene in w
SMN gene in which exon 7 of SMN1 was converted to exon 7 of SMN2; (g)
SMN1 was converted to exon 8 of SMN2.in which exon 7 of SMN1 was converted to exon 7 of
SMN2 (pattern f in Figure 2) was found in 1 (2.4%).
MLPA probe copy numbers of 42 SMA patients are in
Table 1 and inferred copy numbers are in Table 2. Ab-
normal gene structures are in Figure 2.
Gene copy number and structure analysis of unrelated
healthy individuals
Using MLPA assays, 212 healthy Chinese participants
were analyzed. We found that 117 (55.2%) had normal
gene copy numbers for SMN1/SMN2/NAIP (2/2/2) and
54 (25.5%) had different gene copies numbers for SMN1/
SMN2 NAIP (2/1/2). The proportions of the 212 individ-
uals with different copy numbers for the normal SMN1
gene were 1 copy in 4 individuals (1.9%), 2 copies in 203
(95.7%) and 3 copies in 5 (2.4%). The proportions of the
212 with different gene copy numbers for normal SMN2
were 0 copies in 10 (4.7%), 1 copy in 70 (33.0%), 2 copies
in 130 (61.4%) and 3 copies in 2 (0.9%). The proportions
of the 212 with different gene copies for normal NAIP
were 1 copy in 15 (7.1%) and 2 copies in 197 (92.9%).
Genes lacking partial sequences were also found in healthy
participants. Five (2.4%) had an NAIP gene lacking exon 5king exon 5; (b) SMN1 gene lacking exon 7; (c) SMN2 gene lacking
hich exon 8 of SMN2 was converted to exon 8 of SMN1; (f) Hybrid
NAIP gene lacking exon13; (h) Hybrid SMN gene in which exon 8 of
Table 1 The MLPA probe copy numbers of SMA-related genes in 42 Chinese SMA patients
MLPA probe copy number
Total SMN1/SMN2 SMN1 SMN2 NAIP
Group N = 42 Exon1 Exon4 Exon6 Exon8 Exon7 Exon8 Exon7 Exon8 Exon13 Exon5
1 3(7.1%) 2 2 2 2 0 0 2 2 1 1
2 3(7.1%) 2 2 2 2 0 0 2 2 1 0
3 1(2.4%) 2 2 2 2 0 1 2 1 1 0
4 1(2.4%) 2 2 2 2 0 0 2 2 2 1
5 1(2.4%) 3 3 3-4 3 0 0 3 3 2 1
6 1(2.4%) 3 3 3-4 3 0 0 3 3 2 2
7 4(9.5%) 3 3 3 3-4 0 0 3 3 2 2
8 2(4.8%) 4 4 4 4 0 0 4 4 2 2
9 1(2.4%) 3 3-4 3 3 0 1 2 2 2 1
10 2(4.8%) 3 3-4 3-4 3 0 0 2 3 2 2
11 9(21.3%) 3 3-4 3 3-4 0 0 3 3 2 1
12 6(14.2%) 3 3 3 3 0 0 3 3 1 1
13 1(2.4%) 3 3 3 3 0 1 3 2 1 1
14 1(2.4%) 2 2 2 2 0 1 2 1 1 1
15 1(2.4%) 2-3 2-3 3 4 0 0 3 4 2 2
16 2(4.8%) 2-3 3 3 3-4 0 0 3 4 2 1
17 2(4.8%) 1-2 2 2 2 0 0 2 2-3 2 2
18 1(2.4%) 2-3 2-3 3 3 0 1 3 2 2 1
Table 2 Copy numbers of SMA-related genes in 42 Chinese SMA patients determined by MLPA
Total Gene copy number
Pattern Group N = 42 Normal SMN1 gene Normal SMN2 gene Normal NAIP gene Hybrid SMN gene Gene lacking partial sequences
A 1 3(7.1%) 0 2 1 0 0
B 2 3(7.1%) 0 2 0 0 1a
C 3 1(2.4%) 0 1 0 1e 1a
D 4 1(2.4%) 0 2 1 0 1a
E 5 1(2.4%) 0 3 1 0 1a
F 6/7 5(11.9%) 0 3 2 0 0
G 8 2(4.8%) 0 4 2 0 0
H 9 1(2.4%) 0 2 1 0 1a and 1b
I 10 2(4.8%) 0 2 2 0 1c
J 11 9(21.3%) 0 3 1 0 1a
K 12 6(14.2%) 0 3 1 0 0
L 13 1(2.4%) 0 2 1 1e 0
M 14 1(2.4%) 0 1 1 1e 0
N 15 1(2.4%) 0 3 2 0 1d
O 16 2(4.8%) 0 3 1 0 1a and 1d
P 17 2(4.8%) 0 2 2 0 0
Q 18 1(2.4%) 0 2 1 1f 1a
a:NAIP gene lacking exon 5, b:SMN1 gene lacking exon7, c:SMN2 gene lacking exon7, d:SMN2 gene lacking exon 1 to exon 7, e:Hybrid SMN gene in which exon 8 of
SMN2 gene was converted to exon 8 of SMN1, f:Hybrid SMN gene in which exon 7 of SMN1 gene was converted to exon 7 of SMN2.
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lacking exon 13 (pattern g in Figure 2). One person ap-
peared to have an SMN1 gene lacking exon 7 (pattern b in
Figure 2) and an SMN2 gene lacking exon 7 (pattern c in
Figure 2). Three types of hybrid SMN genes were found in
6 of the healthy participants. Four (1.9%) had a hybrid
SMN gene in which exon 8 of SMN2 was converted to
exon 8 of SMN1 (pattern e in Figure 2). Two (0.9%) had a
hybrid SMN gene in which exon 8 of SMN1 was converted
to exon 8 of SMN2 (pattern h in Figure 2). MLPA results
for 212 healthy individuals are in Table 3 and inferred
gene copy numbers are in Table 4. Abnormal gene struc-
tures are in Figure 2.
Differences in distribution of participants by SMN2 and
NAIP gene copy numbers
We examined the distribution of different copy numbers
for the normal SMN2 and NAIP genes in SMA patients
and normal individuals. Distributions by copy number
for normal SMN2 were significantly different in SMA
patients compared to participants without SMA (P <
0.001) (Table 5). Distributions by copy number for nor-
mal NAIP were significantly different for SMA patients
compared to healthy participants (P < 0.001) (Table 6).Table 3 The MLPA probe copy numbers of SMA-related genes
MLPA probe copy number
Total SMN1/SMN2
Group N = 212 Exon1 Exon4 Exon6 Exon8
1 117(55.2%) 4-5 4-5 4 4-5
2 1(0.5%) 4 4 4 4
3 1(0.5%) 4 4-5 4 4
4 54(25.4%) 3-4 3-4 3 3-4
5 1(0.5%) 3 3 3 3
6 7(3.3%) 3-4 3 3-4 3-4
7 1(0.5%) 3-4 3-4 3-4 3
8 4(1.9%) 2 2 2 2
9 5(2.3%) 2 2-3 2-3 2-3
10 1(0.5%) 3 3 3-4 3-4
11 5(2.3%) 4 4-5 4 4
12 1(0.5%) 4 4-5 4 4-5
13 2(0.9%) 4 4-5 4 4-5
14 2(0.9%) 4 4 4 4
15 3(1.4%) 4 4-5 4 4-5
16 2(0.9%) 4-5 5 5 4-5
17 1(0.5%) 4 4-5 4 5
18 1(0.5%) 4-5 5 5 4-5
19 1(0.5%) 4-5 5 4-5 5
20 1(0.5%) 3 3-4 3-4 3-4
21 1(0.5%) 4 4 4 4Discussion
In this study, the copy numbers for SMN1, SMN2 and
NAIP were determined in Chinese SMA patients and
healthy controls using MLPA assays and plausible gene
structures were inferred. We found that 37 (88.1%)
people with SMA had deletions in both exon 7 and exon
8 of SMN1 and the other 5 SMA patients (11.9%) had a
single copy of SMN1 exon 8. These results were similar
to several other studies in different populations [14,15].
Chen et al. reported that a distribution for SMN2 copy
numbers in 94 Chinese SMA patients of 5 copies in 1
patient (1.1%), 4 copies in 24 (25.5%), 3 copies in 47
(50%) and 2 copies in 22 (23.4%). No patients with 0 or 1
copy of SMN2 were found in their population [16]. In
addition, Qu et al. reported that a distribution for SMN2
copy numbers in 232 Chinese SMA patients of 4 SMN2
copies in 13 patients (5.6%), 3 copies in 153(65.9%), 2 cop-
ies in 66(28.5%) and no patients having only 0 or 1 copy of
SMN2 [8]. In our results, the proportion of SMA patients
with a single normal SMN2 copy was 4.8% and no SMA
patients completely lacked copies of SMN2. Although two
SMA patients had a single normal copy of SMN2, they
also had a hybrid SMN gene. These findings indicated that
the proportion of SMA patients with 0 or 1 copy of SMN2in 212 Chinese healthy individuals
SMN1 SMN2 NAIP
Exon7 Exon8 Exon7 Exon8 Exon13 Exon5
2 2 2 2 2 2
2 3 2 1 2 2
2 1 2 3 2 2
2 2 1 1 2 2
2 3 1-2 0 2 2
2 2 1 1 2 3
2 2 1 1 2 4
2 2 0 0 1 2
2 2 0 0 1 3
2 2 1 1 1 1
2 2 2 2 2 3
2 1 2 3 2 3
2 3 2 1 2 3
3 3 1 1 2 2
2 2 2 2 2 1
2 2 3 3 2 2
1 2 1 2 2 2
3 3 2 2 2 3
3 3 2 2 2 1
1 1 2 2 2 1
3 3 1 1 2 3
Table 4 Copy numbers of SMA-related genes in 212 Chinese healthy individuals determined by MLPA
Total Gene copy number










A 1 117(55.2%) 2 2 2 0 0
B 2 1(0.5%) 2 1 2 1 e 0
C 3 1(0.5%) 1 2 2 1 h 0
D 4 54(25.5%) 2 1 2 0 0
E 5 1(0.5%) 2 0 2 1 e 0
F 6/7 8(3.8%) 2 1 2 0 1 g
G 8/9 9(4.2%) 2 0 1 0 1 g
H 10 1(0.5%) 2 1 1 0 0
I 11 5(2.3%) 2 2 2 0 1 g
J 12 1(0.5%) 1 2 2 1 h 1 g
K 13 2(0.9%) 2 1 2 1 e 1 g
L 14 2(0.9%) 3 1 2 0 0
M 15 3(1.4%) 2 2 1 0 1 a
N 16 2(0.9%) 2 3 2 0 0
O 17 1(0.5%) 1 1 2 0 1 b and 1 c
P 18 1(0.5%) 3 2 2 0 1 g
Q 19 1(0.5%) 3 2 1 0 1 a
R 20 1(0.5%) 1 2 1 0 1 a
S 21 1(0.5%) 3 1 2 0 1 g
a:NAIP gene lacking exon 5, b:SMN1 gene lacking exon 7, c:SMN2 gene lacking exon 7, e:Hybrid SMN gene in which exon 8 of SMN2 was converted to exon 8 of
SMN1, g:NAIP gene lacking exon13, h:Hybrid SMN gene in which exon 8 of SMN1 was converted to exon 8 of SMN2.
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report, 2 patients (4.8%) had 4 SMN2 copies, and no pa-
tients had 5 or 6 SMN2 copies. The results revealed that
the proportion of SMA patients with more than 4 SMN2
copies was low in Chinese population. Most of Chinese
SMA patients had 2 or 3 SMN2 copies. The distribution
of normal copy numbers of NAIP in 42 SMA patients
were: homozygous deletion (9.5%), 1 copy (61.9%), and 2
copies (28.6%). This result is similar to data reported by
another two studies of Chinese SMA patients [8,17]. Using
conversions between SMN1 and SMN2 in exons 7 and 8,
six possible hybrid SMN genes were determined [10]. The
hybrid SMN genes of patterns e and f have been reported
in Chinese SMA patients [10,16]. In addition, four types ofTable 5 Comparison of the distribution of SMN2 copy








0 0 (0%) 10 (4.7%)
1 2 (4.8%) 70 (33.1%)
2 14 (33.3%) 130 (61.3%) <0.001
3 24 (57.1%) 2 (0.9%)
4 2 (4.8%) 0 (0%)genes lacking partial sequences were found in SMA pa-
tients in this study. Ten SMA patients had an NAIP gene
lacking exon 5, and this type (pattern a in Figure 2) of de-
letion was also found in several studies [7,18,19]. Three
patients had an SMN2 lacking exon 1 to exon 7 (pattern d
in Figure 2), and two had an SMN2 lacking exon 7 (pat-
tern c in Figure 2). We also inferred that one patient had
an SMN1 lacking exon 7 (pattern b in Figure 2). For all we
know, this study is the first report of three types of SMN
(pattern b, c, d) lacking partial sequence.
The SMA-related genes of 212 Chinese healthy indi-
viduals were analyzed using MLPA assays. Zhu et al. re-
ported that 1% of healthy Chinese individuals have four
SMN1 copies [2]. However, no individuals with 4 copies
of SMN1 were found in our study. In addition, we iden-
tified 4 participants with a single normal SMN1 copy,Table 6 Comparison of the distribution of NAIP copy








0 4 (9.5%) 0 (0%)
1 26 (61.9%) 15 (7.1%) <0.001
2 12 (28.6%) 197 (92.9%)
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ported frequency of SMA carriers is 2.4% in the general
Chinese population [2,16], therefore, our carrier fre-
quency was lower. In contrast to the SMA patients, no
homozygous deletions of NAIP were found in healthy
Chinese participants. In addition to the hybrid SMN
gene e in SMA patients, the hybrid SMN gene in which
exon 8 of SMN1 was converted to exon 8 of SMN2 (pat-
tern h in Figure 2) was found in healthy participants; this
type of the hybrid SMN gene has been reported previ-
ously [10,20]. Four types of genes lacking partial se-
quences (pattern a, b, c, g in Figure 2) were found in
healthy individuals of our study. The proportion of
healthy individuals (2.4%) with an NAIP gene lacking
exon 5 was lower than for SMA patients (23.8%). This
result might indicate that deletion of exon 5 in NAIP is
involved in the molecular basis of SMA. Of the healthy
participants, 27 (12.7%) had an NAIP gene with an exon
13 deletion, and this type of NAIP gene was not found
in SMA patients. One SMA carrier had a ratio of 1:2 for
exon 7 and 8 of SMN1 and a ratio of 1:2 for exon 7 and
8 of SMN2. We hypothesized that she had an SMN1
lacking exon 7 (pattern b in Figure 2) and an SMN2
lacking exon 7 (pattern c in Figure 2).
The distributions of different copy numbers for nor-
mal SMN2 were compared between Chinese SMA pa-
tients and healthy individuals and distributions were
significantly different (P < 0.001) between SMA patients
and people without SMA (Table 5). Similarly, in a study
of 108 SMA patients and 22 healthy controls, Crawford
et al. found that the SMN2 copy number was signifi-
cantly lower in control subjects [21]. Thus, SMA pa-
tients appeared to be prone to having more SMN2
copies than the controls. Because of the lack of SMN
protein, fewer copies of SMN2 decrease the likelihood of
survival to birth. This might explain the difference in the
distribution of people with different SMN2 copy numbers.
We also analyzed the distribution of copy numbers of nor-
mal NAIP in SMA patients and people without SMA and
found significant differences (P < 0.001) (Table 6). Com-
pared with healthy people, SMA patients had fewer NAIP
copies. NAIP modifies the clinical phenotypes of SMA pa-
tients. Patients with fewer copies of NAIP might have
more severe clinical symptoms of SMA [6,7]. This might
be why that distribution of NAIP copies was significantly
different between people with and without SMA. The
NAIP gene locus is near the SMN1 gene locus, and both
are located at 5q13.2. We determined that some SMA pa-
tients had a large deletion in the SMN1 and NAIP loci.
This could partially explain why SMA patients had fewer
NAIP copies than people without SMA.
Currently, SMN1 is recognized as an SMA causing gene.
In contrast, the SMN2 and NAIP have been characterized
as a modifying factor of the clinical severity of SMA. So,the clinical diagnosis and prenatal diagnosis of SMA are
mainly based on the identification of SMN1 copy numbers
and the situation of the SMN1 gene exon7 [22-24]. The
copy numbers of SMN2 and NAIP were used to evaluate
the clinical phenotype of SMA patients [25,26]. According
to our results, the differences between the SMA patients
and healthy controls were not only the distribution of
SMA-related genes, the gene structures were also differ-
ent. Moreover, the proportions of abnormal gene struc-
tures were high in both SMA patients (36%) and healthy
controls (17%). Our data revealed that only confirming the
gene copy numbers may not be sufficient to the clinical
diagnosis, prenatal diagnosis, phenotype evaluation and
carrier screening of SMA. The abnormal gene structures
should be taken into account in the clinical diagnosis of
SMA. So the analyses of SMA-related gene structures
were also important to the molecular diagnostics of SMA
patients and carriers.
At present, most of previous studies about Chinese
SMA disease only focused on SMA patients or healthy
population. There were few articles about comparison and
analysis of SMA-related genes and gene structures in the
Chinese people with and without SMA. In this study, we
compared copy numbers of SMN1, SMN2 and NAIP be-
tween Chinese SMA patients and healthy controls and in-
ferred gene structures. We summarized the subdivision of
SMA-related gene patterns (Tables 2 and 4) based on the
MLPA technique. The genetic characteristics would be
helpful for the further identification of the clinical subdiv-
ision of SMA patients. There are limitations of our study.
All gene copy numbers and gene structures were inferred
from MLPA results, so we didn’t know the detailed haplo-
type of each participant. Therefore, further investigations
are needed.Conclusions
In conclusion, we analyzed and compared gene copy num-
bers and gene structures in Chinese SMA patients and
healthy individuals. For the first time three types of SMN
lacking partial sequence were found. The distributions of
different copy numbers for normal SMN2 and NAIP were
significantly different between SMA patients and healthy
controls. The gene structures of SMN and NAIP were also
different between the SMA patients and healthy controls.
Further studies are required to address the molecular
mechanisms and clinical diagnoses of SMA.Abbreviations
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